发明名称 |
Therapeutic use of estrogen receptor (ER)beta-selective agonists for triggering somatotropic, organotropic and anticatabolic effects (somatotropic therapy) |
摘要 |
This invention describes the use of estrogen receptor (ER)beta-selective agonists for the production of a pharmaceutical agent for triggering somatotropic and/or organotropic effects in the CNS, the circulatory system, the skeletal system and/or the immune system in the aging male and female organism (anticatabolic therapy).
|
申请公布号 |
US2003130249(A1) |
申请公布日期 |
2003.07.10 |
申请号 |
US20020272290 |
申请日期 |
2002.10.17 |
申请人 |
SCHERING AG |
发明人 |
ELGER WALTER;REDDERSEN GUDRUN;SCHNEIDER BIRGITT;HILLISCH ALEXANDER;PETERS OLAF;KOSEMUND DIRK;MULLER GERD |
分类号 |
A61K31/00;A61K31/56;A61K31/565;(IPC1-7):A61K31/56 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|